Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. White House responds to Pope Leo’s rebuke of Trump peace plan for Ukraine After winning his ...

While still in early stages, the Janus program could redefine energy resilience, mission assurance, and America’s forward defense posture. In November 2025, the Department of the Army announced the ...

STATEWIDE — GOV. KATHY HOCHUL has launched POWER UP, a $300 million initiative to make New York’s industrial sites both shovel-ready and power-ready for next-generation industries, including ...

Since energy regulators approved the first recipient in June, about one loan has been announced per month. The most recent loan — a third for NRG — was announced on Nov. 20. Tom Fox / TNS AUSTIN — ...

Losing your phone can leave you in panic mode, especially when the battery dies. The good news is that both Apple and Android offer built-in tools that help you track a missing device even when it is ...

The shale play that provides the most US energy production is struggling to find ways to power itself. Operators and service companies in the Permian basin, the most prolific US region at about 6 ...

WASHINGTON — As part of next steps for the Janus Program, the Department of the Army has selected nine installations for consideration in which to site microreactor power plants, and the Defense ...

Grab this rare material for Celeste's Tribute to Toledo quest. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. For this quest, I'd recommend ...

Waseem is a writer here at GameRant. He can still feel the pain of Harry Du Bois in Disco Elysium, the confusion of Alan Wake in the Remedy Connected Universe, the force of Ken's shoryukens and the ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...